InspireMD AAQS

Que fait InspireMD ? InspireMD Inc, listed on the stock market with ticker NSPR and ISIN US45779A8466, is a medical device company based in Tel Aviv-Yafo, Israel. The company operates within the Health Care sector, specifically in the Health Care industry. InspireMD has 127 employees and went public through an IPO on April 12, 2013. Its website is http://www.inspiremd.com/. The company focuses on developing and commercializing stent platform technology for treating complex vascular and coronary diseases. InspireMD's MicroNet is a micron mesh sleeve designed to wrap around a stent, providing embolic protection during stenting procedures. The company also offers the CGuard carotid embolic prevention system, which integrates MicroNet with a self-expandable nitinol stent for carotid artery applications. Additionally, InspireMD markets the MGuard Prime Embolic Protection System, a bare-metal cobalt-chromium stent, for coronary disease treatment in the European Union. The MGuard Prime EPS is also intended for use in patients with acute coronary syndromes, including acute myocardial infarction and saphenous vein graft coronary interventions. The company is developing a neurovascular flow diverter called NGuard, an endovascular device. InspireMD's technology aims to enhance safety and efficacy in vascular and coronary interventions by preventing embolic events during stent placement. InspireMD est l'une des entreprises les plus populaires sur Eulerpool.